| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/22/1990 | WO1990001496A1 Polypeptides and dna encoding same |
| 02/22/1990 | WO1990001338A1 Leukocyte adhesion inhibitor |
| 02/20/1990 | US4902618 Production of hybridoma antibodies for interferon |
| 02/20/1990 | US4902615 Diagnostic kit for cancer |
| 02/14/1990 | EP0354729A2 Cytotoxic drug conjugates |
| 02/14/1990 | EP0354728A2 Cytotoxic drug conjugates |
| 02/13/1990 | US4900661 Method for immunological determination of amines, monoclonal antibodies and kit of reagents for carrying out the method |
| 02/08/1990 | WO1990001066A1 Porcine polyclonal and monoclonal antibodies |
| 02/08/1990 | WO1990001063A1 New secretory leader sequences |
| 02/07/1990 | EP0354109A1 Recombinant HBsAg hybrid particles having morphological characteristics of the HBsAg antigen and containing an immunogenic sequence which induces neutralizing antibodies directed against HIV or susceptible of being recognized by such antibodies. Nucleotide sequences coding for such particles and vaccines containing them |
| 02/07/1990 | EP0354072A1 Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens |
| 02/07/1990 | EP0353814A2 Synthetic peptide endowed with immunological activity, capable of inducing the production of antibodies with a high specificity towards alpha-fetoprotein, and their use in the diagnostic field |
| 02/06/1990 | CA1265648A1 Leukemia-associated virus immunogen, vaccine and assay |
| 01/31/1990 | EP0353111A1 Nucleic acid or fragments thereof encoding the P30 protein of Toxoplasma gondii, methods for their preparation and uses thereof |
| 01/31/1990 | EP0352761A2 Antigens composed of "major histocompatibility complex" class I antigens and specific carrier molecules, their production and use |
| 01/31/1990 | EP0352707A2 An expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from streptomyces |
| 01/25/1990 | WO1990000609A1 Cellulose binding fusion proteins |
| 01/25/1990 | WO1990000565A1 Interleukin ii analogs |
| 01/25/1990 | WO1990000405A1 Immunoconjugates for cancer diagnosis and therapy |
| 01/25/1990 | WO1990000403A1 Genetically engineered coccidiosis vaccine |
| 01/24/1990 | EP0352119A2 Vampire bat salivary plasminogen activators |
| 01/24/1990 | EP0352073A1 Vectors, cells transformed thereby, and their use in producing heterologous polypeptides |
| 01/24/1990 | EP0351944A1 Monoclonal antibodies to immunogenic human interleukin-3 peptide |
| 01/17/1990 | EP0351244A2 Antibodies and methods for immunochemical assay using them |
| 01/16/1990 | US4894443 Polypeptides, antibodies |
| 01/16/1990 | US4894436 Genetic engineering, polypeptides |
| 01/11/1990 | WO1990000178A1 Platelet blocking peptides |
| 01/10/1990 | EP0350230A2 Immunoconjugates for cancer diagnosis and therapy |
| 01/10/1990 | EP0349594A1 Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
| 01/09/1990 | US4892827 Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects |
| 01/03/1990 | EP0348442A1 Altered antibody |
| 12/28/1989 | WO1989012683A1 Nucleic acid encoding the p30 protein of toxoplasma gondii |
| 12/28/1989 | WO1989012641A1 Enterically transmitted non-a/non-b hepatitis viral agent |
| 12/28/1989 | WO1989012462A1 Enterically transmitted non-a/non-b hepatitis viral agent |
| 12/28/1989 | WO1989012459A1 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 12/28/1989 | WO1989012458A1 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
| 12/28/1989 | WO1989009829A3 Methods of generating desired amino-terminal residues in proteins |
| 12/27/1989 | EP0347781A2 Mini-proinsulin, its oroduction and use |
| 12/27/1989 | EP0347435A1 Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins |
| 12/27/1989 | EP0347433A1 Recombinant antibody |
| 12/26/1989 | US4889800 Synthetic polypeptides and receptor molecules derived therefrom and methods of use |
| 12/26/1989 | US4889798 Biotinylated polynucleotide, streptavidin and lecithin |
| 12/20/1989 | EP0347365A2 HIV-2 virus variants |
| 12/20/1989 | EP0346430A1 Proteins and process for preparing them, dna sequences, antibodies and their application, poxvirus, transformed or infected cells and pharmaceutical compositions useful for preventing toxoplasmosis |
| 12/20/1989 | EP0346370A1 Synthetic anti-caries vaccine |
| 12/19/1989 | US4888398 Biodegradable polypeptide and the use thereof for the gradual release of drugs |
| 12/19/1989 | US4888280 Nucleotide sequence; dna transfer vector |
| 12/14/1989 | WO1989012109A1 Gene therapy using gene fusions for genetic or acquired disorders |
| 12/14/1989 | WO1989012108A1 Immunochemical assay for human granulocyte-macrophage colony stimulating factor |
| 12/14/1989 | WO1989012092A1 Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
| 12/13/1989 | EP0346316A2 Fusion protein and its use |
| 12/13/1989 | EP0346087A2 Hybrid antibody and process for the production thereof |
| 12/13/1989 | EP0345906A2 Unique elastase induced fibrinogen cleavage site antigens |
| 12/13/1989 | EP0345792A2 HTLV-I / HIV-1 fusion proteins |
| 12/13/1989 | EP0345315A1 Ps2 protein derivative |
| 12/13/1989 | EP0221114B1 A process for the production of a protein |
| 12/13/1989 | CN1037925A Monoclonal antibodies |
| 12/12/1989 | US4886743 Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof |
| 12/06/1989 | EP0344957A1 Immunochemical assay for human granulocyte-macrophage colony stimulating factor |
| 12/05/1989 | US4885166 Hybrid interferons |
| 12/05/1989 | CA1263618A1 Hybrid particle immunogens |
| 11/30/1989 | WO1989011538A1 Platelet-specific chimeric immunoglobulin |
| 11/30/1989 | WO1989011489A1 Immunogenic human interleukin-3 peptide and monoclonal antibodies thereto |
| 11/30/1989 | WO1989011296A1 Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen |
| 11/29/1989 | EP0343946A2 Cea fragments |
| 11/29/1989 | EP0343460A2 P. falciparum CS-peptides as universal T-cell epitope |
| 11/29/1989 | EP0343186A1 MOLECULES COMPRISING AT LEAST ONE PEPTIDIC SEQUENCE CARRYING ONE OR A PLURALITY OF EPITOPES CHARACTERIZING A PROTEIN PRODUCED BY -i(P. FALCIPARUM) IN HEPATOCYTES AND COMPOSITIONS CONTAINING THEM. |
| 11/21/1989 | US4882271 Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection |
| 11/21/1989 | US4882145 T cell epitopes of the hepatitis B virus nucleocapsid protein |
| 11/16/1989 | WO1989010967A1 Recombinant flagellin vaccines |
| 11/16/1989 | WO1989010939A1 Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens |
| 11/16/1989 | DE3910084A1 Polypeptide mit wachstumsfaktor-aktivitaet und nukleinsaeuresequenzen Polypeptides with growth factor activity and nucleic acid sequences of |
| 11/15/1989 | EP0341304A1 Improved ricin molecules and ricin toxin conjugates |
| 11/15/1989 | EP0341287A1 Diagnostic methods and systems for quantifying apo ai |
| 11/15/1989 | EP0341252A1 Human polymorphic epithelial mucin polypeptides for use in therapy and diagnosis |
| 11/15/1989 | CN1037174A Novel revombinant and chimeric antibodies directed against human adenocarcinoma |
| 11/08/1989 | EP0341100A2 DNA coding for thymosin and TNF |
| 11/08/1989 | EP0340948A1 Novel hybrid pesticidal toxins |
| 11/08/1989 | EP0340604A2 Monoclonal antibody and its use |
| 11/08/1989 | CN1036988A Antibody heteroconjugates for use in regulation lymphocyte activity |
| 11/07/1989 | US4879225 Enhanced production of antibodies utilizing insolubilized immune complexes |
| 11/07/1989 | US4879212 Peptide composition and method for the detection of antibodies to HTLV-III |
| 11/07/1989 | CA1262799A1 Broad spectrum vaccine against gonorrhea |
| 11/02/1989 | WO1989010412A1 Detection of neu gene expression and products |
| 11/02/1989 | WO1989010405A1 Chimeric glycoproteins containig immunogenic segments of human parainfluenza virus type 3 |
| 11/02/1989 | WO1989010135A1 Hybrid peptides and methods of their use |
| 11/02/1989 | EP0340198A1 Immunoassay for the detection of alpha-haloacetamides |
| 11/02/1989 | EP0339163A2 Monoclonal antibodies specific for HIV and hybridomas for their production |
| 10/25/1989 | EP0338846A2 Monoclonal antibodies |
| 10/25/1989 | EP0338767A2 Novel recombinant and chimeric antibodies directed against a human adenocarcinoma antigen |
| 10/25/1989 | EP0338745A1 Method for producing recombinant DNA proteins |
| 10/25/1989 | EP0338437A2 Synthetic vaccins against foot and mouth disease and their preparation process |
| 10/25/1989 | EP0192657B1 Monoclonal antibody directed to human ganglioside gd 2? |
| 10/19/1989 | WO1989009829A2 Methods of generating desired amino-terminal residues in proteins |
| 10/19/1989 | WO1989009825A1 Method for producing recombinant dna proteins |
| 10/19/1989 | WO1989009622A1 Il-2 receptor-specific chimeric antibodies |
| 10/17/1989 | CA1262333A1 Using monoclonal antibodies specific for treponema bacterial pathogens |
| 10/11/1989 | EP0336441A2 Anti-CPBII monoclonal antibody |
| 10/11/1989 | EP0336405A2 Anti-human cancer protein complexes, their production and use |
| 10/11/1989 | EP0336379A2 Antibody heteroconjugates for use in regulation of lymphocyte activity |